Articles tagged with Antibiotic Resistance
Researchers mapped global trends in antimicrobial resistance rates among food animals in low- and middle-income countries between 2000 and 2018. The study found that antibiotic-resistant bacteria are on the rise, with high rates of resistance identified in antibiotics commonly used in food production.
A study found that nearly two-thirds of Danish hedgehogs carried mecC-MRSA, a type of antibiotic-resistant bacteria. However, there was no evidence of transmission from hedgehogs to humans or rehabilitators, dispelling fears about hedgehog visits in gardens.
A new study reveals a significant increase in antibiotic-resistant pathogens in chickens and pigs worldwide, particularly in developing countries. The researchers identified hotspots of resistance, including China and India, where more than half of the world's pigs and chickens are raised.
Scientists have detected extensively drug-resistant Salmonella strains in central Africa that are resistant to nearly all commonly available drugs, a significant threat to public health. The study reveals that these new strains exhibit genetic and behavioral changes that suggest ongoing evolution towards bloodstream infections.
The proportion of bacteria resistant to antimicrobials has increased significantly worldwide, with critical consequences for animal health and human consumers. A new map reveals high resistance rates in regions such as northeast China, northeast India, and southern Brazil, where key antibiotics have lost efficacy.
Researchers at Procarta Biosystems are developing a new type of antimicrobial that kills bacteria by blocking gene expression, potentially revolutionizing treatment of serious and life-threatening infections. The £7.4m funding from CARB-X aims to combat antibiotic resistance, a major global threat.
Scientists engineer a plasmid that removes antibiotic resistance genes from Enterococcus faecalis, reducing its abundance by threefold in mouse models. The technology uses CRISPR-Cas9 and aims to combat antimicrobial resistance in hospitals.
Researchers from Florida Atlantic University and Georgia Aquarium have found a significant increase in antibiotic resistance in bottlenose dolphins, with the prevalence of resistance to at least one antibiotic reaching 88.2 percent. The study's findings suggest that the isolates originated from human activities or discharges, highlight...
Researchers from Osaka University found that a relatively ancient Haemophilus influenzae drug efflux pump AcrB confers resistance to antibiotics similar to its more evolved counterparts. The study highlights the evolution and mechanism of multidrug efflux systems, suggesting a 'one size fits all' approach is not suitable.
A Wistar team is advancing a synthetic DNA technology called DNA-encoded monoclonal antibodies (DMAbs) to combat multidrug-resistant Pseudomonas aeruginosa. The researchers have demonstrated the effectiveness of DMAbs in controlling infection in mice, paving the way for further development and clinical testing.
Infections acquired by patients in Canadian hospitals are declining, with a 30% reduction between 2009 and 2017, reveals new research published in CMAJ. Urinary tract infections were the most common type of infection, followed by pneumonia and surgical site infections.
Treating preterm infants with antibiotics for more than 20 months can lead to less diverse bacterial populations in their gut, containing more antibiotic resistance genes. The study suggests that early-life antibiotic use may promote allergies and other health issues later in life by reducing the diversity of microbial communities.
Researchers create new way to detect resistant bacteria, enabling clinicians to reserve stronger antibiotics for most patients. The modified antibiotic can be attached to a sensor surface to detect resistance enzymes, paving the way for rapid diagnostic tests.
Researchers found a new mechanism for resistance gene transmission in intestinal bacteria that's independent of antibiotics. Persistent bacteria can survive and share genes with other bacteria, spreading resistance, according to ETH Zurich scientists.
A new study modelled the effects of antibiotic prescriptions on developing antibiotic-resistant bacteria in the River Thames. Reducing antibiotic use by 80% is necessary to avoid a surge in superbugs, which could pose a more immediate risk to humanity than climate change.
Bacteria behind hospital infections have been found to close tiny doors in their cell walls, blocking antibiotics. This mechanism allows researchers to design new drugs that can 'pick the locks' and allow antibiotics into bacterial cells.
A Montreal hospital's switch from ward-type rooms to private rooms led to a significant decrease in multidrug-resistant organism colonization and health care-associated infections. The study suggests that such changes can have a positive impact on patient safety.
A team of Australia-UK researchers identified the molecular machinery used by bacteria to resist chemicals, which could be repurposed to produce precursors for new polymers like nylon. This discovery sheds light on how bacteria develop resistance and may lead to the development of new antimicrobial agents.
Resistance to carbapenems and polymyxins is geographically widespread in Southeast Asia, with overlapping distributions in eight countries. The study highlights the urgent need for robust antimicrobial resistance surveillance and improved infection prevention and treatment practices globally.
Researchers extracted genetic programs for glycopeptide antibiotic production from Actinobacteria, revealing precursors date back over 1 billion years. The study shows that resistance co-evolved with production as a means of self-protection for producing bacteria.
Researchers at Rice University and UTHealth have discovered that vancomycin-resistant Enterococci (VRE) can develop resistance to daptomycin in more than one way. The study's findings provide new insights into the mechanisms of antibiotic resistance, which could lead to the development of new treatment strategies or 'co-drugs' targetin...
Researchers found that cigarette smoke can change the DNA and characteristics of pathogenic microbes like MRSA, making them more resistant to antibiotics. This stress response sparks an emergency mutation, resulting in hardy variants that are better equipped to resist drugs.
Antibiotic-resistant genes were found in London's freshwater sources, with the River Thames having the highest levels. The genes come from human and animal waste, which contaminates water bodies through wastewater discharge. Researchers are now experimenting with slow sand filtration to remove these genes.
A recent study found that nearly 9% of healthy women carried multi-drug resistant Escherichia coli strains in their guts, which can transfer to the female urinary tract and cause disease. The study also showed that these strains persist in the gut for a long time and can be detected in the urine without symptoms.
A recent study found that kissing is a significant route of transmission for gonorrhoea, with rates of infection higher among men who kiss their partners compared to those who do not. The researchers argue that increased awareness and control measures are needed to address the rising global incidence of gonorrhoea.
Researchers at Inserm and Université de Rennes 1 have created new antibiotics effective against Gram-positive and negative multi-resistant bacteria. The compounds, known as peptidomimetics, also appear to prevent the development of resistance when used in mice models.
A new study from King's College London found that GP antibiotic prescribing has decreased overall, but at a slower rate for older patients and those with unclear diagnoses. The study analyzed data from 102 general practices in England from 2014 to 2017 and showed a 6.9% decline in total antibiotic prescribing per year.
Researchers discovered that multiple antibiotic resistance mutations in E. coli acquired simultaneously, rather than through gradual evolution. This finding suggests a recent emergence of the pandemic multidrug-resistant strain, possibly within the last 12 years.
Research reveals high levels of antibiotic resistance among E. coli and other Enterobacteriaceae species in Ghana, posing a significant threat to the healthcare system. The spread of these resistant bacteria through contact with contaminated surfaces and person-to-person contact is a major public health concern.
Researchers have identified a combination of penicillin and clavulanic acid that can overcome resistance in some MRSA strains, making them potentially effective against the superbug. The study suggests that existing medicines could be used to treat one of the world's major strains of MRSA.
The University of Liverpool and LSTM have received £3.54m funding to develop a personalized approach to prevent and treat antimicrobial resistance (AMR). The project aims to use AI, deep learning, and real-time monitoring to provide individualized treatment options for patients.
Researchers found Cannabidiol effective in killing a wide range of Gram-positive bacteria, including resistant strains, and disrupted biofilms. The compound retained its activity under extended exposure conditions that lead to resistance against other common antibiotics.
Researchers found that six probiotic Bacillus strains are resistant to various types of drugs and can still grow in their presence. The study aims to determine if these bacteria can transfer antibiotic resistance to harmful bacteria, posing a threat to human health.
Scientists found high levels of clinically relevant AMR bacteria in urban wildlife in Nairobi, carrying a significant risk to human health. The study highlights the importance of taking an ecological approach to addressing antimicrobial resistance by improving urban planning and waste management practices.
Scientists at Emory Health Sciences have found that combining certain antibiotics can effectively target and defeat bacteria with heteroresistance, a previously underappreciated form of antibiotic resistance. This approach may offer a new strategy for treating resistant infections in hospitalized patients.
An observational study found that human contact was responsible for 90% of the spread of one species of antibiotic-resistant bacteria to new patients. However, the same level of transmission was not seen with another species, highlighting the need for multiple prevention strategies.
Researchers at North Carolina State University discovered a gene that makes Salmonella resistant to colistin, the drug of last resort for treating multidrug-resistant infections. The mcr-3.1 gene was found in a human patient who had traveled to China two weeks prior to becoming ill with a Salmonella infection.
A systematic review of government policies aimed at reducing human antimicrobial use identified 17 types of interventions, but most were not rigorously evaluated. The authors recommend that governments ensure AMR policy interventions are tested using rigorous study designs to avoid future waste of public resources.
Researchers discovered a new class of antibiotics produced by the microbiome that kill bacteria by disrupting their energy metabolism. Fibupeptides, such as lugdunin, have shown promise in treating multidrug-resistant infections, including those caused by MRSA.
Scientists explore the emergence of novel genes and functional proteins from random DNA sequences, revealing peptides that confer high resistance to aminoglycosides. The study demonstrates how de novo evolution can be studied experimentally in the laboratory.
Researchers at Stellenbosch University studied how Mycobacterium tuberculosis develops resistance to bedaquiline, a new anti-TB drug. The study found that resistance can emerge despite adherence to the standard treatment regimen, highlighting the need for improved monitoring and diagnostic tools.
Researchers at Swansea University have found that Manuka honey is effective in killing antimicrobial resistant bacteria by 39%, improving the activity of some antibiotics. This could provide an alternative treatment for cystic fibrosis patients struggling with deadly, antibiotic-resistant respiratory infections.
A new study has helped develop a treatment option for multi-drug resistant (MDR) infections, including complicated urinary tract infections. The treatment, tebipenem pivoxil hydrobromide, is an oral antibiotic agent that may facilitate earlier discharge from hospital or treat complex infections in the community.
Scientists at the University of Sheffield have discovered a new compound that kills antibiotic-resistant gram-negative bacteria, including E. coli. The compound's unique properties make it difficult for resistance to emerge in the bacteria, paving the way for new treatment options.
Researchers observe DNA transmission between resistant and sensitive Escherichia coli bacteria, discovering a generalist efflux pump facilitating minimal protein synthesis activity. This study opens new avenues for understanding bacterial resistance mechanisms and potential therapeutic applications.
Researchers discovered that previously drug-sensitive bacteria can survive exposure to antibiotics long enough to express resistance genes, rendering them immune. The mechanisms underlying this process involve a drug-jettisoning pump and horizontal gene transfer mechanisms like bacterial conjugation.
A new modeling study suggests that rapid tests for drug-resistant infections could turn the tables against bacteria, allowing doctors to target resistant strains with precision. However, the researchers found that asymptomatic carriers must also be screened and treated to reverse the spread of resistance.
A leading scientist proposes five rules to tackle antibiotic resistance, including protecting new drugs and using diverse antimicrobials. The World Health Organisation warns of a post-antibiotic era, and the study aims to provide a roadmap for integrated microbial management.
BioBits Health, a Northwestern University-led project, introduces CRISPR and antibiotic resistance to high school students. Students perform experiments using freeze-dried cell-free reactions, visualizing DNA editing and drug resistance, and exploring ethics.
A new compound, C10, was discovered to increase the effectiveness of frontline antibiotic isoniazid against Mycobacterium tuberculosis (Mtb), a deadly disease. The study suggests that antibiotic resistance in Mtb may be reversible.
A new drug combination of gentamicin and azithromycin shows promising results in treating treatment-resistant gonorrhoea, with a cure rate of 91% compared to 98% for the current ceftriaxone treatment. The study suggests that gentamicin could be used as an alternative for patients who are allergic or intolerant to ceftriaxone.
A team of scientists, led by microbiologist Marjon de Vos, conducted a review to explore the application of evolutionary theory in clinical microbiology. By analyzing microbial communities and genetic data, they identified potential solutions for treating cystic fibrosis patients and limiting the spread of antibiotic resistance.
Researchers analyzed over 850 drug-resistant E. coli genomes to identify survival strategies, finding that clones use niche separation and NFDS to evolve and succeed in the host environment. The study's findings highlight the importance of understanding bacterial ecology to develop effective prevention methods.
Researchers found that a 'superbug' clone of E. coli called ST131 has evolved to prevent itself from becoming the sole dominant clone, allowing it to colonize the human gut more competitively than other strains. The discovery provides insight into how this process happens and may help develop strategies to prevent it.
Researchers developed a drug resistance index to track global trends in antibiotic therapy effectiveness. The study found that high-income countries generally have lower rates of resistance, while low- and middle-income countries face greater challenges due to limited access to newer drugs.
Scientists have created a genetically engineered bacterium that can specifically kill multiple antibiotic-resistant bacteria without harming beneficial bacteria. The novel tool, based on the CRISPR-Cas9 system, has shown a minimal rate of emergence of new resistance and has potential applications in treating infectious diseases.
Researchers discovered a gene that enables bacteria to resist linezolid in cats and dogs at a UK animal hospital, suggesting potential transmission between animals and humans.
A study of 230 travelers found that staying in hotels increases the risk of contracting multi-drug resistant bacteria by four times. Younger travelers aged 20-30 are particularly at risk, and people visiting certain regions face a higher risk of infection with ESBL-producing Enterobacteriaceae.
A European study finds associations between antibiotic resistance and seasonal temperature, with significant contributions to MRSA variance. Climate change may increase AMR transmission, particularly carbapenem resistance, in various healthcare systems.
A UK study found that only one-third of patients with suspected urinary tract infections (UTIs) actually have evidence of the infection. In reality, nearly all patients receive antibiotics, which contributes to antimicrobial resistance. The study suggests implementing antimicrobial stewardship initiatives could reduce unnecessary antib...